Prostate Cancer Survivors With Rising PSA and Their Spouses: Treatment Decision Making and Quality of Life
Abstract
This study involves patients and their spouses/partners who are attending two cancer centers: the Deane Prostate Health and Research Center in the Department of Urology at Mount Sinai Hospital, New York City and the Department of Medical Oncology at Fox Chase Cancer Center, Philadelphia. Patients will have been diagnosed with rising PSA but have no clinical evidence of cancer. Eligible patients and their spouse/partners who have agreed to participate (n = 191) will take part in a 12-months long assessment study. During this time, they will be interviewed via questionnaires four times: at the beginning (baseline), at 6-months, at 12-months and when they have made a treatment decision. Our research focus and the measures used for data collection are guided by our cognitive-social health information processing (CSHIP) theoretical framework. This framework incorporates individuals' experiences, expectations, beliefs, values, and emotional responses to a health threat, and sees these components as influential factors in treatment decision making. Both the patient and the spouse/partner will be assessed. Due to the limited patient enrollment, no significant findings can be reported at this time.
Document Details
- Document Type
- Technical Report
- Publication Date
- Dec 01, 2007
- Accession Number
- ADA479405
Entities
People
- Michael A. Diefenbach
Organizations
- Icahn School of Medicine at Mount Sinai